BiPAP vs CPAP: 2026 Physician-Reviewed Respiratory Device Comparison

QUICK ANSWER — BiPAP vs CPAP

CPAP delivers one continuous pressure and is the standard first-line treatment for obstructive sleep apnea (OSA). BiPAP delivers two pressures — a higher pressure for inhalation (IPAP) and a lower pressure for exhalation (EPAP) — and is prescribed when CPAP fails, or for conditions including COPD with CO₂ retention (hypercapnia), central sleep apnea (CSA), or obesity hypoventilation syndrome (OHS). Both CPAP and BiPAP are FDA Class II prescription-only devices in the United States.

→ Full BiPAP vs CPAP comparison with condition table ↓
→ Not sure which device you need? Start here: Which Device Is Right for Me? ↓

Introduction

If you’ve just received a CPAP or BiPAP prescription — or you’re comparing respiratory devices before your next specialist appointment — this physician-authored guide covers everything you need to make a confident, informed decision. Each section gives you a direct clinical answer, a condition-specific suitability table, and cost and insurance context for the five major home respiratory device categories: pulse oximeters, CPAP vs BiPAP machines, nebulizers, and oxygen concentrators.

Three questions come up in almost every pre-appointment conversation:

• Which device actually matches my diagnosis?
• Will insurance cover it?
• Do I need a prescription?

This guide answers all three — for every device category on this page.

Part of our complete respiratory device guide. Reviewed by Dr. Rishav Das, M.B.B.S. — Consumer Device Accuracy Specialist. 7 peer-reviewed references cited. Updated June 2026.

This page is for you if:

  • You’ve just been diagnosed with sleep apnea, COPD, or a related condition and are researching your first device.

  • You’re comparing devices before your next specialist appointment.

  • You’re a caregiver helping a family member choose the right respiratory equipment.

New to respiratory devices? Jump to → “Which Device Is Right for Me?” (decision guide below)

📖  Plain-language note: Medical terms are explained the first time they appear. For example:

  • cmH₂O — the unit for measuring air pressure in PAP machines (think of it as a “gentle push” of air)

  • IPAP / EPAP — the two pressure settings in a BiPAP machine: one for breathing in, one for breathing out

  • LPM — litres per minute; the flow rate of oxygen delivered   • MMAD — the average particle size produced by a nebulizer; smaller particles reach deeper into the lungs

Which Respiratory Device Is Right for You?

Answer these four quick questions to find your comparison:

STEP 1 — What are you managing?

  A)  Sleep apnea (snoring, gasping, daytime fatigue) → See CPAP vs BiPAP

  B)  Low blood oxygen / COPD / lung disease → See Oxygen Concentrators

  C)  Asthma or inhaled medication delivery → See Nebulizers

  D)  I just want to monitor my oxygen levels at home → See Pulse Oximeters

STEP 2 — Do you have a prescription?

  Yes → You’re ready to compare models. Use the sections below.

  No  → Start with Pulse Oximeters (no prescription needed) and the “When to Consult” section.

STEP 3 — What’s your budget?

  Under $200 → Pulse oximeter or jet nebulizer

  $200–$1,000 → Fixed CPAP or home nebulizer

  $1,000+ or insurance-covered → APAP, BiPAP, or oxygen concentrator

STEP 4 — Do you need to travel with your device?

 Yes → Prioritise: wearable oximeter / mesh nebulizer / portable oxygen concentrator / travel-sized APAP  

No  → Home units offer better output and value

A fingertip pulse oximeter is accurate to ±2% at SpO₂ levels of 90–100% when FDA 510(k)-cleared and used on a well-perfused, nail-polish-free fingertip at rest — this is the ISO 80601-2-61 standard that medical-grade devices must meet. Wearable devices have wider accuracy ranges (±2–4%) and are more sensitive to motion artifact. For quick spot-checks during illness, post-exercise recovery, or altitude monitoring, a fingertip oximeter is sufficient. For overnight oxygen monitoring in COPD, heart failure, or suspected nocturnal hypoxemia, a dedicated wearable oximeter or clinical home sleep study is more appropriate.

Two primary form factors are available: fingertip (spot-check) devices and wearable (continuous monitoring) devices. Each has distinct accuracy characteristics, clinical use cases, and FDA clearance implications — detailed below.

SpO₂ Accuracy: FDA 510(k) Standards and What They Mean for Home Monitoring

Key Accuracy Considerations:

• The FDA has noted that most pulse oximeters are validated in individuals with SpO₂ ≥ 70%; accuracy at lower saturations may be limited [1]
• Studies have identified potential overestimation of SpO₂ in individuals with darker skin pigmentation — a recognized limitation documented across both device types [2]
• Motion artifact is a primary source of error in wearable devices during activity or sleep

⚠️ Clinical Note: No consumer-grade pulse oximeter should be used as the sole basis for medical decision-making. Arterial blood gas (ABG) analysis remains the clinical gold standard for oxygen saturation measurement.

Continuous vs Spot SpO₂ Monitoring: When Each Type Matters

Pulse Oximeter Use Cases by Clinical Situation

Prescription Requirement: Fingertip oximeters rated as OTC Class I do not require a prescription. Medical-grade (Class II, 510(k)-cleared) oximeters intended for prescription monitoring may require a physician order depending on jurisdiction and intended use.

Pulse Oximeter Accuracy by Skin Tone: What FDA and NEJM Evidence Shows

The U.S. Food and Drug Administration issued a Safety Communication in February 2021 noting that pulse oximeters may be less accurate in individuals with darker skin pigmentation. A 2020 study published in the New England Journal of Medicine (Sjoding et al.) found that Black patients were nearly three times as likely to have occult hypoxemia — low blood oxygen undetected by pulse oximetry — compared to white patients. This limitation applies to both medical-grade and consumer pulse oximeters.

Pulse oximeters use red and infrared light to estimate oxygen saturation through the fingertip. Melanin pigmentation absorbs some of these wavelengths, which can cause the device to overestimate SpO₂ — reporting a reading within normal range when true blood oxygen is actually lower. This is not a minor calibration issue; it represents a clinically significant accuracy gap.

The U.S. Food and Drug Administration issued a Safety Communication in February 2021 noting that pulse oximeters may be less accurate in individuals with darker skin pigmentation [1]. A 2020 study published in the New England Journal of Medicine (Sjoding et al.) found that Black patients were nearly three times as likely to have occult hypoxemia — low blood oxygen undetected by pulse oximetry — compared to white patients [2].

This limitation applies to both medical-grade and consumer pulse oximeters. It should be discussed explicitly with your clinician if you have darker skin and are monitoring a respiratory or cardiovascular condition at home. Arterial blood gas (ABG) testing remains the clinical gold standard where SpO₂ accuracy is critical.

CPAP delivers a single continuous pressure and is the first-line treatment for obstructive sleep apnea (OSA). BiPAP delivers two pressures — one for inhalation (IPAP) and one for exhalation (EPAP) — and is clinically indicated when patients cannot tolerate CPAP, or when conditions such as COPD with hypercapnia, central sleep apnea (CSA), or obesity hypoventilation syndrome (OHS) are present. Both devices are FDA Class II prescription-only devices in the United States.

For most people newly diagnosed with OSA, CPAP is the correct starting point. BiPAP is prescribed when CPAP fails or when the diagnosis specifically calls for bilevel pressure support — not as a general upgrade. The sections below explain every difference in clinical detail: pressure mechanics, condition-specific suitability, comfort, and cost.

How CPAP and BiPAP Deliver Pressure Differently: IPAP, EPAP, and Pressure Support Explained

Pressure titration for both devices must be performed by a licensed sleep medicine or respiratory therapy specialist. Self-adjusting pressures without clinical guidance is not recommended.

CPAP vs BiPAP by Diagnosis: OSA, COPD, Central Sleep Apnea, and Obesity Hypoventilation Syndrome

⚠️ Prescription Requirement: Both CPAP and BiPAP are prescription devices in the United States (FDA Class II). A physician-issued prescription based on a sleep study or clinical evaluation is required for purchase and insurance coverage.

Comfort, Adaptation, and Exhalation Resistance: CPAP vs BiPAP

CPAP vs BiPAP Cost, Insurance, and DME Coverage

💡  Cost note: Both CPAP and BiPAP are covered by Medicare Part B and most private insurance plans when prescribed following a qualifying sleep study. HSA/FSA funds can be used for out-of-pocket costs.    → Check if your insurance qualifies

Ready to compare specific CPAP and BiPAP models? →  See our top-rated CPAP machines for 2025 — reviewed by sleep specialists 

Fixed CPAP vs APAP (Auto-Titrating): What the Cochrane Evidence Shows

Fixed CPAP delivers one prescribed pressure all night. APAP automatically adjusts pressure within a clinician-set range in response to apnea events and flow limitation. A 2012 Cochrane systematic review found no significant difference in AHI reduction between fixed CPAP and APAP in patients with uncomplicated obstructive sleep apnea — but APAP may improve treatment compliance in some patients by delivering lower average pressure. APAP is not appropriate for central sleep apnea, COPD, or obesity hypoventilation syndrome.

Fixed CPAP delivers one prescribed pressure all night. APAP (Auto-Titrating CPAP) automatically adjusts pressure within a clinician-set range in response to apnea events, snoring, and flow limitation.

A 2012 Cochrane systematic review found no statistically significant difference in AHI (Apnea-Hypopnea Index — the number of breathing interruptions per hour of sleep) reduction between fixed CPAP and APAP in patients with uncomplicated obstructive sleep apnea [6] — but APAP may improve treatment compliance in some patients by delivering lower average pressure. APAP is not appropriate for central sleep apnea, COPD, heart failure with Cheyne-Stokes breathing, or hypoventilation syndromes.

Effectiveness Comparison:

• A Cochrane systematic review found no statistically significant difference in AHI reduction between fixed CPAP and APAP in patients with uncomplicated OSA [6]
• APAP may provide a modest improvement in compliance in some patient populations due to lower average delivered pressure [6]
• APAP is generally not recommended for patients with CSA, COPD, heart failure with CSA, or hypoventilation syndromes — fixed or BiPAP/ASV therapy is preferred in these groups [3]

When APAP Is and Is Not Clinically Appropriate

APAP may be appropriate when:

• You have uncomplicated obstructive sleep apnea (OSA).
• Pressure needs vary during the night due to:
  • Sleep position changes
  • Different sleep stages
  • Nasal congestion
  • Weight fluctuations
• Greater comfort and lower average pressure delivery may improve therapy adherence.

APAP may not be appropriate when:

• You have central sleep apnea (CSA).
• You have obesity hypoventilation syndrome (OHS).
• You have chronic hypercapnic respiratory failure.
• You have certain forms of COPD or other complex breathing disorders.

Bottom line: APAP is designed primarily for obstructive sleep apnea and should be prescribed based on a sleep specialist’s evaluation of the underlying condition and treatment goals.

Important: Auto-titrating CPAP is not appropriate if you have central sleep apnea, COPD, or heart failure with Cheyne-Stokes breathing. Your doctor will guide this.

Medication Compatibility and Particle Size by Nebulizer Type

Treatment Time and Delivery Efficiency Compared

Clinical Relevance of Treatment Time:

• Mesh nebulizers typically finish a treatment in under 8 minutes — so your child’s session is done before frustration has a chance to set in, and adults with severe breathlessness spend less time struggling with the device. [7]
• Evidence suggests mesh nebulizers deliver a higher proportion of respirable particles per unit time compared to jet nebulizers in bench studies [7]
• Clinical equivalence in patient outcomes across nebulizer types depends on medication, patient technique, and device settings — consult a respiratory therapist for individualized guidance

Portability, Noise, and Pediatric Nebulizer Considerations

If you’re on supplemental oxygen and wondering whether you can still take that trip — or whether a portable unit will actually deliver enough oxygen for a full night’s sleep — this comparison answers those questions directly. Home concentrators are designed for bedside all-night use; portable models give you freedom but come with trade-offs in flow rate and battery life.

Oxygen concentrators extract and concentrate oxygen from ambient air using a molecular sieve (Pressure Swing Adsorption — PSA) process, eliminating the need for compressed oxygen tanks. Two primary form factors exist: stationary home concentrators (HOC) and portable oxygen concentrators (POC).

⚠️ Prescription Requirement: Supplemental oxygen therapy requires a physician prescription in the United States. Oxygen flow rate and delivery method (continuous flow vs pulse dose) must be specified by the prescribing clinician based on documented hypoxemia.

Pulse Dose vs Continuous Flow Oxygen: A Clinically Important Distinction

Pulse dose oxygen delivers oxygen only during inhalation, triggered by breath detection. Continuous flow delivers oxygen throughout the entire breathing cycle. Pulse dose delivery is not appropriate for patients with high respiratory rates, irregular breathing, or significant hypoxemia at rest — those patients require continuous flow. The delivery mode must be specified in the oxygen prescription by the treating physician.

Bottom Line: Pulse dose oxygen prioritizes portability, battery efficiency, and mobility, making it a popular choice for travel and daily activities. Continuous flow oxygen provides a steady, uninterrupted oxygen supply and is generally preferred for patients with higher oxygen requirements, significant resting hypoxemia, or overnight oxygen therapy. The appropriate mode should always be determined by your healthcare provider based on your prescription, oxygen saturation levels, and clinical condition.

Output Capacity, Flow Rate, and High-Flow Prescriptions Compared

⚠️ Clinical Note: Pulse dose delivery is not equivalent to continuous flow delivery for all patients. Patients requiring oxygen during sleep, or those with higher ventilatory demands, may not achieve adequate oxygenation with pulse dose alone. This distinction must be addressed by the prescribing clinician.

Power, Portability, and Battery Life for Oxygen Concentrators

Flying with a Portable Oxygen Concentrator: FAA Approval and Airline Rules

Most airlines allow travel with an FAA-approved portable oxygen concentrator (POC).

POCs are permitted because they generate oxygen from ambient air and meet aviation safety requirements. Contact your airline 48 to 72 hours before departure to confirm its medical device policy. Some airlines require a physician statement that includes:

• Your diagnosis
• Prescribed oxygen flow rate
• Confirmation that you are fit to fly

Carry enough battery capacity to power the device for at least 150% of total travel time, including delays. Verify whether your prescription requires pulse dose or continuous flow oxygen, as not all POCs provide both modes. Review airline-specific requirements before travel to avoid boarding issues or treatment interruptions

Medicare DME Coverage and Cost for Oxygen Concentrators

💡  Can’t afford the full purchase price?

Most home and portable oxygen concentrators are covered by Medicare Part B as Durable Medical Equipment (DME), and most private insurers follow similar criteria. If you have a valid prescription documenting hypoxemia (low blood oxygen), you may pay little to nothing out of pocket. Many DME suppliers also offer monthly rental plans starting under $200/month — with the option to return the device if your oxygen needs change. Ask your supplier about rent-to-own arrangements before committing to a purchase.

SpO₂ Accuracy Standards: Medical-Grade vs Consumer Oximeters

FDA 510(k) Classification and Approval

When a Consumer Device Is Acceptable vs When Medical-Grade Is Required

⚠️ Critical Note: The FDA issued a Safety Communication in 2021 noting that pulse oximeters may be less accurate in individuals with darker skin pigmentation and cautioning against reliance on these devices for clinical decisions. This applies to both medical-grade and consumer devices [1]. Consumers and clinicians should be aware of these limitations.

Do You Need a Prescription for CPAP, BiPAP, or an Oxygen Concentrator?

In the United States, CPAP, BiPAP, and all positive airway pressure devices are classified as FDA Class II prescription medical devices. A physician-issued prescription based on a documented sleep study or clinical evaluation is required before purchase or insurance reimbursement. Home oxygen concentrators also require a prescription specifying flow rate and delivery method. OTC fingertip pulse oximeters are FDA Class I and do not require a prescription for general wellness use.

In the United States, CPAP, BiPAP, and all positive airway pressure devices are classified as FDA Class II prescription medical devices. A physician-issued prescription — based on a documented sleep study (in-lab polysomnography or a qualifying home sleep test) or clinical evaluation — is required before purchase or insurance reimbursement.

Home and portable oxygen concentrators also require a prescription specifying the flow rate and delivery method (pulse dose or continuous flow). The prescription must be issued by the treating physician based on documented hypoxemia.

Fingertip pulse oximeters sold over-the-counter (OTC) are FDA Class I and do not require a prescription for general wellness monitoring. Medical-grade (Class II, 510(k)-cleared) pulse oximeters for specific clinical monitoring may require a physician order depending on intended use.

Nebulizers are Class II devices. The prescription requirement typically applies to the medication loaded into the nebulizer, not the device itself — though policies vary by supplier and insurer.

When to Consult a Healthcare Provider Before Purchasing a Respiratory Device

This section is provided for educational purposes only. Medical oversight standards for this content are described on our About page.

How to Get Your Respiratory Device Covered by Insurance or Medicare

Medicare Part B (Durable Medical Equipment):

CPAP, BiPAP, and oxygen concentrators are covered under Medicare Part B as DME when:

  • You have a qualifying diagnosis confirmed by a physician

  • For CPAP/BiPAP: a sleep study (in-lab PSG or qualifying home sleep test) documents AHI ≥ 5

  • For oxygen: documented resting SpO₂ ≤ 88% or PaO₂ ≤ 55 mmHg

What Medicare typically covers: 80% of the approved amount after your Part B deductible. Your supplemental insurance covers the rest in most cases.

Prior Authorization:

BiPAP, auto-BiPAP, and high-flow oxygen concentrators often require prior authorization. Your physician’s office handles this — ask them to confirm it’s been submitted before your device is ordered.

HSA / FSA Funds:

All devices on this page — pulse oximeters, CPAP/BiPAP machines, nebulizers, and oxygen concentrators — are HSA/FSA-eligible expenses. If you have funds expiring at year-end, this is a qualified use.

Private Insurance:

Coverage criteria mirror Medicare in most plans. Request a Letter of Medical Necessity (LMN) from your prescribing physician — most insurers require this for initial approval.

If Your Claim Is Denied:

You have the right to appeal. Ask your DME supplier for help with the appeals process — most have dedicated insurance teams for this. →  Questions about your specific plan? Contact your insurer’s DME benefits line directly.

Continue Learning About Respiratory Devices

This page provides comparative information to support educational understanding of respiratory device categories. For personalized device recommendations, prescription guidance, or clinical evaluation, consult a licensed healthcare provider.

Understand every device in detail → Complete Respiratory Device Guide (how each type works, explained in plain English)

Ready to choose? → Respiratory Device Buying Guide — our step-by-step selection framework by condition and budget

See what we recommend → Best CPAP Machines, Pulse Oximeters & Oxygen Concentrators for 2025 — editorially reviewed by sleep specialists

References

World Health Organization. Pulse oximetry training manual. 2011. https://www.who.int/patientsafety/safesurgery/pulse_oximetry/en/

U.S. Food and Drug Administration. Pulse Oximeter Accuracy and Limitations: FDA Safety Communication. February 19, 2021. https://www.fda.gov/medical-devices/safety-communications/pulse-oximeter-accuracy-and-limitations-fda-safety-communication

Sjoding MW, Dickson RP, Iwashyna TJ, Gay SE, Valley TS. Racial Bias in Pulse Oximetry Measurement. New England Journal of Medicine. 2020;383(25):2477-2478. doi:10.1056/NEJMc2029240

Epstein LJ, Kristo D, Strollo PJ Jr, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. Journal of Clinical Sleep Medicine. 2009;5(3):263-276. PMID: 19960649

Cowie MR, Woehrle H, Wegscheider K, et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine. 2015;373(12):1095-1105. doi:10.1056/NEJMoa1506459 [SERVE-HF Trial]

Köhnlein T, Windisch W, Köhler D, et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. The Lancet Respiratory Medicine. 2014;2(9):698-705. doi:10.1016/S2213-2600(14)70153-5

Ip S, D’Ambrosio C, Patel K, et al. Auto-titrating versus fixed continuous positive airway pressure for the treatment of obstructive sleep apnea: a systematic review with meta-analyses. Systematic Reviews. 2012;1:20. doi:10.1186/2046-4053-1-20

Ari A, Fink JB. Aerosol therapy in pulmonary critical care. Respiratory Care. 2017;62(6):745-758. doi:10.4187/respcare.05203

Centers for Medicare & Medicaid Services. Medicare Benefit Policy Manual, Chapter 15 — Covered Medical and Other Health Services. (Oxygen and Oxygen Equipment, Section 110.) https://www.cms.gov/

National Institutes of Health, National Heart, Lung, and Blood Institute. CPAP for Sleep Apnea. https://www.nhlbi.nih.gov/

Save this guide for later:

   Get our free Respiratory Device Selection Checklist — straight to your inbox 

↗  Know someone dealing with sleep apnea or COPD?

   Share this comparison →